UCB Sues Synthon Over ANDA For Xyzal
Belgian drugmaker UCB SA and its U.S. partner, Sepracor Inc., are suing Synthon Pharmaceuticals Inc. over the company's planned generic version of the antihistamine Xyzal....To view the full article, register now.
Already a subscriber? Click here to view full article